← 홈

ADC

1,068개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,068개
ADCBiologicstaleBristol-Myers SquibbPhase 2

MORAb-202 (MORAb-202)

Carcinoma, Non-Small-Cell Lung · Neoplasms, Ovarian

#NeoplasmsOvarian#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 20%임상시험 4상태 DISCONTINUED
ADCBiologicstaleNektar TherapeuticsPhase 2

NKTR-255 (NKTR-255)

Multiple Myeloma; Non-Hodgkin Lymphoma · Locally Advanced or Metastatic Urothelia

#LocallyAdvancedorMetastaticUroth#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 4상태 RECRUITING
ADCBiologicstaleRochePhase 2

trastuzumab (Herceptin, Patritumab and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 4상태 RECRUITING
ADCBiologicstaleSanofiPhase 2

SAR439459 (SAR439459)

Plasma Cell Myeloma Refractory · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD19A (SGN-CD19A)

Burkitt Lymphoma; Precursor B-cell Lymphoblastic Leukemia-Lymphoma · CD19

#CD19#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 4상태 ACTIVE
ADCBiologicstaleShanghai Yuansong Biotechnology…Phase 2

YSCH-01 (YSCH-01)

Recurrent Glioblastoma · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 2

denintuzumab mafodotin (denintuzumab mafodotin)

Lymphoma, B-cell; Lymphoma, Large B-Cell, Diffuse · Lymphoma, B-cell

#LymphomaB-cell#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 4상태 DISCONTINUED
ADCBiologicstaleRochePhase 3

polatuzumab vedotin, zanubrutinib, rituximab and lenalidomide (polatuzumab vedotin, zanubrutinib, rituximab and lenalidomide)

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleAbbVie (prior sponsor, Abbott)Phase 1

ABT-700 (ABT-700)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0%임상시험 3상태 ACTIVE
ADCBiologicPfizerPhase 2

ALLR3 (ALLR3)

ACUTE LYMPHOBLASTIC LEUKEMIA · ACUTE LYMPHOBLASTIC LEUKEMIA

#ACUTELYMPHOBLASTICLEUKEMIA#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 3상태 RECRUITING
ADCBiologicQuantumLeap Healthcare Collabor…Phase 2

ARV-471 + Letrozole (ARV-471 + Letrozole)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 3상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 3

AZD5335 (AZD5335)

Epithelial Ovarian Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicAstraZenecaPLPhase 2

AZD8205 (AZD8205)

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 3상태 RECRUITING
ADCBiologicstaleBio-Thera SolutionsPhase 1

BAT8001 (BAT8001)

HER2-Positive Solid Tumors · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 ACTIVE
ADCBiologicBiocity Biopharmaceutics Co., L…Phase 1

BC3195 (BC3195)

Advanced Cancer; Metastatic Solid Tumor · Advanced Cancer

#AdvancedCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleSeagenPhase 2

brentuximab vedotin (Adcetris, Brentuximab Vedotin, anti-PD-1 antibody.)

Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma · PD-1

#PD-1#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

Bv-AVD-R (Bv-AVD-R)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING
ADCBiologicstaleBioAtla, Inc.Phase 2

CAB-AXL-ADC (CAB-AXL-ADC)

Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma · Undifferentiated Pleomorphic Sarcoma

#UndifferentiatedPleomorphicSarco#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 ACTIVE
ADCBiologicstaleBioAtla, Inc.Phase 2

CAB-ROR2-ADC (CAB-ROR2-ADC)

Non Small Cell Lung Cancer; Triple Negative Breast Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 ACTIVE
ADCBiologicstaleConvalife (Shanghai) Co., Ltd.Phase 2

CVL006 (CVL006)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 3상태 RECRUITING

29 / 54 페이지

← 이전다음 →